Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 2Phase 2 1Phase 1 1

Status

Recruiting 3Not yet recruiting 3

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 2400Neoplasms 1819Carcinoma, Non-Small-Cell Lung 1599Prostatic Neoplasms 1298Colorectal Neoplasms 1140Lung Neoplasms 984Neoplasm Metastasis 830Multiple Myeloma 792Leukemia, Myeloid, Acute 767Ovarian Neoplasms 674Pancreatic Neoplasms 662Melanoma 660Squamous Cell Carcinoma of Head and Neck 586Carcinoma, Hepatocellular 567Recurrence 562Brain Neoplasms 527Glioblastoma 513Head and Neck Neoplasms 500Stomach Neoplasms 497Triple Negative Breast Neoplasms 465Lymphoma 454Uterine Cervical Neoplasms 450Carcinoma, Renal Cell 425Precursor Cell Lymphoblastic Leukemia-Lymphoma 410Lymphoma, Non-Hodgkin 389Endometrial Neoplasms 381Sarcoma 368Lymphoma, Follicular 356Urinary Bladder Neoplasms 354Hematologic Neoplasms 352

Interventions

Immune Checkpoint Inhibitors 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Solid Cancers × 1 year × Clear all
NCT07510841 2026-04-06

JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR

Biotech Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
228 enrolled

Solid Cancers

NCT07479667 2026-03-18

dendritic cell

Shanghai Cell Therapy Group Co.,Ltd

Phase 1 Recruiting
8 enrolled

Solid Cancers

NCT07427186 2026-02-25

MINER2

Institut Claudius Regaud

Phase NA Not yet recruiting
600 enrolled

Solid Cancers

NCT03514368 2026-02-19

MINER

Institut Claudius Regaud

Phase NA Recruiting
770 enrolled

Solid Cancers

NCT07170293 2025-09-12

Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors

Tianjin Medical University Second Hospital

Phase 2 Recruiting
15 enrolled

Solid Cancers

NCT07030478 2025-06-22

A Study to Evaluate the Safety and Tolerability of EP0089

Ellipses Pharma

Phase 1/2 Not yet recruiting
190 enrolled
Other solid neoplasm

Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡